Hanson R N, Holman B L, Davis M A
J Med Chem. 1978 Aug;21(8):830-3. doi: 10.1021/jm00206a025.
Iodinated analogues 2, 7, and 8 were prepared from propranolol, practolol, and acebutolol in 30--50% yields. Radioisotopic exchange between carrier-free Na125I and the molten iodinated beta-adrenergic antagonist yielded the corresponding 125I-labeled product. The biodistribution in rats, determined at 15 and 60 min postinjection, indicated that the radioiodinated analogues of the cardioselective drugs practolol and acebutolol localized to a greater degree in the liver and heart than the analogue of propranolol. Conversely, [125I]iodopropranolol (2) was concentrated to a greater extent in the lungs than [125I]iodopractolol (7) or [125I]iodoacebutolol (8). Therefore, 123I- or 131I-labeled cardioselective beta-adrenergic antagonists, such as 7 or 8, may prove useful as radiodiagnostic agents for the external imaging of the myocardium.
碘代类似物2、7和8由普萘洛尔、醋丁洛尔和心得宁制备,产率为30%-50%。无载体的Na125I与熔融的碘代β-肾上腺素能拮抗剂之间的放射性同位素交换产生了相应的125I标记产物。在注射后15分钟和60分钟测定的大鼠体内生物分布表明,心脏选择性药物醋丁洛尔和心得宁的放射性碘代类似物在肝脏和心脏中的定位程度高于普萘洛尔的类似物。相反,[125I]碘普萘洛尔(2)在肺中的富集程度高于[125I]碘醋丁洛尔(7)或[125I]碘心得宁(8)。因此,123I或131I标记的心脏选择性β-肾上腺素能拮抗剂,如7或8,可能被证明是用于心肌外部成像的放射性诊断剂。